Search research articles
Contact Us
Filters
Showing results (241-250 of 296) with videos related to
Page
of 30
Sort By:
The New England Journal of Medicine
|
August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Mikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
European Heart Journal
|
August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)
Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Lancet (London, England)
|
April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Javed Butler, Sanjiv J Shah, Mark C Petrie, et al.
Lancet (London, England)
|
November 9, 2015
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A Michael Lincoff, Roxana Mehran, Thomas J Povsic, et al.
Circulation
|
September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Stephan Windecker, Renato D Lopes, Tyler Massaro, et al.
The New England Journal of Medicine
|
April 8, 2024
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Mikhail N Kosiborod, Mark C Petrie, Barry A Borlaug, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
European Journal of Preventive Cardiology
|
November 6, 2016
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
Lluís Mont, Antonio Pelliccia, Sanjay Sharma, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology
|
May 19, 2021
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement
Uri Landes, Guy Witberg, Janarthanan Sathananthan, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 296) with videos related to
Sort By:
Page
of 30
The New England Journal of Medicine
|
August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Mikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
European Heart Journal
|
August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)
Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Lancet (London, England)
|
April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Javed Butler, Sanjiv J Shah, Mark C Petrie, et al.
Lancet (London, England)
|
November 9, 2015
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A Michael Lincoff, Roxana Mehran, Thomas J Povsic, et al.
Circulation
|
September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Stephan Windecker, Renato D Lopes, Tyler Massaro, et al.
The New England Journal of Medicine
|
April 8, 2024
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Mikhail N Kosiborod, Mark C Petrie, Barry A Borlaug, et al.
The New England Journal of Medicine
|
September 1, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
Pablo Garcia-Pavia, Martin S Maron, Ahmad Masri, et al.
European Journal of Preventive Cardiology
|
November 6, 2016
Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
Lluís Mont, Antonio Pelliccia, Sanjay Sharma, et al.
Journal of the American College of Cardiology
|
December 5, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial
Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, et al.
JAMA Cardiology
|
May 19, 2021
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement
Uri Landes, Guy Witberg, Janarthanan Sathananthan, et al.
Page
of 30